Different effects of raloxifene and estrogen on interleukin-1β and interleukin-1 receptor antagonist production using in vitro and ex vivo studies

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

JAMA · 2002 · 15.8K citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Molecular basis of agonism and antagonism in the oestrogen receptor

A.M. Brzozowski, A.C.W. Pike, Zbigniew Dauter et al. · Nature · 1997 · 3.3K citations

Life Sciences, Endocrinology, Pharmacology +14

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis

Stavros C. Manolagas · Endocrine Reviews · 2000 · 1.3K citations

Medicine, Cell Biology, Developmental Biology +14

Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. <i>JAMA</i> 2002; 288(3): 321-333

Dr Ailsa Gebbie · Journal of Family Planning and Reproductive Health Care · 2002 · 1.2K citations · Full text

Medicine, Endocrinology, Gynecology +11